# Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies

> **NCT01949844** · NA · COMPLETED · sponsor: **Daniel S. Berman** · enrollment: 44 (actual)

## Conditions studied

- Coronary Artery Disease
- CAD

## Interventions

- **DRUG:** regadenoson
- **DRUG:** Optimark®
- **DEVICE:** Myocardial perfusion MRI

## Key facts

- **NCT ID:** NCT01949844
- **Lead sponsor:** Daniel S. Berman
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-16
- **Primary completion:** 2017-01-15
- **Final completion:** 2017-10-23
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2018-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01949844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01949844, "Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01949844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*